iBio Inc.

About iBio

iBio, Inc. develops and offers pharmaceutical product applications using its iBio Technology platform.

About

A Leader In The Plant-Made Pharmaceutical Field

iBio, Inc. develops pharmaceutical product applications using its iBio Technology platform; a platform that has proven to be more efficient and cost-effective than traditional systems.

The iBio Technology has been validated by major industry players, as well as the Brazilian government, opening iBio’s doorway to the world market.

With extensive patent protection and proprietary know-how, iBio creates a high barrier to entry for competitors.

$100+ million in R&D in the iBio Technology Platform*
$646M+ iBio Total Brazilian Market Opportunity**
60+ 60+ issued patents in various countries, 20 U.S.
*~$70M of the total RD spend was from non-dilutive funding provided by from development partners and other third parties
** iBio market size estimates. These opportunities are under evaluation and discussion, and may or may not include Bio-Manguinhos participation.

Global Market

Global Market

iBio’s global commercialization program, which was started in the favorable Brazilian market, is also licening the iBio Technology to key U.S. companies

About our Go-To Market Strategy
Global Market
iBio Technology

iBio Technology

The iBio Technology platform is a proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins and has been validated across a wide range of applications in both vaccines and biotherapeutics.

Learn More

Product Pipeline

IBIO-CFB03

iBio is developing a proprietary therapeutic product for the treatment of idiopathic pulmonary fibrosis (IPF), systemic scleroderma and other fibrotic diseases

View IBIO-CFB03
Phase completed
not started
not started
not started
not started
not started
Preclinical Phase 1 Phase 2a Phase 2b Phase 3 Market

Learn More About Partnerships

iBio is establishing partnerships through iBio Technology platform licensing arrangements and product collaborations.

Interested in Becoming a Partner?